Literature DB >> 23583750

Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.

Richard S Kao1, Marcia J Abbott, Alyssa Louie, Dylan O'Carroll, Weidar Lu, Robert Nissenson.   

Abstract

Osteocytes have been implicated in the control of bone formation. However, the signal transduction pathways that regulate the biological function of osteocytes are poorly defined. Limited evidence suggests an important role for the Gs/cAMP pathway in osteocyte function. In the present study, we explored the hypothesis that cAMP-dependent kinase A (PKA) activation in osteocytes plays a key role in controlling skeletal homeostasis. To test this hypothesis, we mated mice harboring a Cre-conditional, mutated PKA catalytic subunit allele that encodes a constitutively active form of PKA (CαR) with mice expressing Cre under the control of the osteocyte-specific promoter, DMP1. This allowed us to direct the expression of CαR to osteocytes in double transgenic progeny. Examination of Cre expression indicated that CαR was also expressed in late osteoblasts. Cortical and trabecular bone parameters from 12-week old mice were determined by μCT. Expression of CαR in osteocytes and late osteoblasts altered the shape of cortical bone proximal to the tibia-fibular junction (TFJ) and produced a significant increase in its size. In trabecular bone of the distal femur, fractional bone volume, trabecular number, and trabecular thickness were increased. These increases were partially the results of increased bone formation rates (BFRs) on the endosteal surface of the cortical bone proximal to the TFJ as well as increased BFR on the trabecular bone surface of the distal femur. Mice expressing CαR displayed a marked increase in the expression of osteoblast markers such as osterix, runx2, collagen 1α1, and alkaline phosphatase (ALP). Interestingly, expression of osteocyte marker gene, DMP1, was significantly up-regulated but the osteocyte number per bone area was not altered. Expression of SOST, a presumed target for PKA signaling in osteocytes, was significantly down-regulated in females. Importantly, no changes in bone resorption were detected. In summary, constitutive PKA signaling in osteocytes and late osteoblasts led to a small expansion of the size of the cortical bone proximal to the TFJ and an increase in trabecular bone in female mice. This was associated with down-regulation of SOST and up-regulation of several osteoblast marker genes. Activation of the PKA pathway in osteocytes and late osteoblasts is sufficient for the initiation of an anabolic skeletal response. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583750      PMCID: PMC3690773          DOI: 10.1016/j.bone.2013.04.001

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  65 in total

1.  Parathyroid hormone-activated volume-sensitive calcium influx pathways in mechanically loaded osteocytes.

Authors:  A Miyauchi; K Notoya; Y Mikuni-Takagaki; Y Takagi; M Goto; Y Miki; T Takano-Yamamoto; K Jinnai; K Takahashi; M Kumegawa; K Chihara; T Fujita
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  Cre recombinase-dependent expression of a constitutively active mutant allele of the catalytic subunit of protein kinase A.

Authors:  Colleen M Niswender; Brandon S Willis; Angela Wallen; Ian R Sweet; Thomas L Jetton; Brian R Thompson; Chaodong Wu; Alex J Lange; G Stanley McKnight
Journal:  Genesis       Date:  2005-11       Impact factor: 2.487

3.  PTH receptors and apoptosis in osteocytes.

Authors:  F R Bringhurst
Journal:  J Musculoskelet Neuronal Interact       Date:  2002-03       Impact factor: 2.041

4.  A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.

Authors:  H Jüppner; A B Abou-Samra; M Freeman; X F Kong; E Schipani; J Richards; L F Kolakowski; J Hock; J T Potts; H M Kronenberg
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

5.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

6.  Intermittent administration of human parathyroid Hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice.

Authors:  A Sakai; T Sakata; S Ikeda; S Uchida; R Okazaki; T Norimura; M Hori; T Nakamura
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

7.  PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells.

Authors:  Akira Suzuki; Keiichi Ozono; Takuo Kubota; Hiroki Kondou; Kanako Tachikawa; Toshimi Michigami
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

8.  Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass.

Authors:  Edward C Hsiao; Benjamin M Boudignon; Wei C Chang; Margaret Bencsik; Jeffrey Peng; Trieu D Nguyen; Carlota Manalac; Bernard P Halloran; Bruce R Conklin; Robert A Nissenson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

Review 9.  Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy.

Authors:  Yoon S Cho-Chung; Maria Nesterova; Kevin G Becker; Rakesh Srivastava; Yun Gyu Park; Youl Nam Lee; Yee Sook Cho; Meyoung-Kin Kim; Catherine Neary; Chris Cheadle
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

10.  PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.

Authors:  Yumie Rhee; Matthew R Allen; Keith Condon; Virginia Lezcano; Ana C Ronda; Carlo Galli; Naomi Olivos; Giovanni Passeri; Charles A O'Brien; Nicoletta Bivi; Lilian I Plotkin; Teresita Bellido
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

View more
  10 in total

1.  Female-Specific Role of Progranulin to Suppress Bone Formation.

Authors:  Liping Wang; Theresa Roth; Mary C Nakamura; Robert A Nissenson
Journal:  Endocrinology       Date:  2019-09-01       Impact factor: 4.736

Review 2.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

3.  Adenylyl cyclase 3 regulates osteocyte mechanotransduction and primary cilium.

Authors:  Michael P Duffy; McKenzie E Sup; X Edward Guo
Journal:  Biochem Biophys Res Commun       Date:  2021-08-12       Impact factor: 3.322

4.  Inactivation of Osteoblast PKC Signaling Reduces Cortical Bone Mass and Density and Aggravates Renal Osteodystrophy in Mice with Chronic Kidney Disease on High Phosphate Diet.

Authors:  Ariane Zaloszyc; Philippe Choquet; Amira Sayeh; Maria Bartosova; Betti Schaefer; Ulrike Huegel; Gaëlle Aubertin-Kirch; Christopher Healy; François Severac; Sébastien Rizzo; Georges Boivin; Franz Schaefer; Michel Fischbach; Justine Bacchetta; Seiamak Bahram; Claus Peter Schmitt
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

5.  The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass.

Authors:  Martin Pellicelli; Julie A Miller; Alice Arabian; Claude Gauthier; Omar Akhouayri; Joy Y Wu; Henry M Kronenberg; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

6.  Deficiency of the intermediate filament synemin reduces bone mass in vivo.

Authors:  Megan C Moorer; Atum M Buo; Karla P Garcia-Pelagio; Joseph P Stains; Robert J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2016-09-07       Impact factor: 5.282

7.  AKAP2 identified as a novel gene mutated in a Chinese family with adolescent idiopathic scoliosis.

Authors:  Wei Li; YaWei Li; Lusi Zhang; Hui Guo; Di Tian; Ying Li; Yu Peng; Yu Zheng; Yuliang Dai; Kun Xia; Xinqiang Lan; Bing Wang; Zhengmao Hu
Journal:  J Med Genet       Date:  2016-03-17       Impact factor: 6.318

8.  Elevated Protein Kinase A Activity in Stomach Mesenchyme Disrupts Mesenchymal-epithelial Crosstalk and Induces Preneoplasia.

Authors:  Pawan Puri; Garfield Grimmett; Rawah Faraj; Laurielle Gibson; Ebony Gilbreath; Bradley K Yoder
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-06-09

9.  Negative Skeletal Effects of Locally Produced Adiponectin.

Authors:  Marcia J Abbott; Theresa M Roth; Linh Ho; Liping Wang; Dylan O'Carroll; Robert A Nissenson
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

10.  Connexin 43 Channels in Osteocytes Regulate Bone Responses to Mechanical Unloading.

Authors:  Dezhi Zhao; Ruofei Liu; Guobin Li; Meng Chen; Peng Shang; Hui Yang; Jean X Jiang; Huiyun Xu
Journal:  Front Physiol       Date:  2020-03-31       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.